Skip to content

Prospective comparison of plasma- or serum-based assays of D-dimer and fibrin degradation product for diagnosing periprosthetic joint infection

The diagnostic value of plasma/serum fibrinolysis in periprosthetic infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038547
Enrollment
Unknown
Registered
2020-09-23
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip and knee joint disease

Interventions

Gold Standard:The definition and diagnostic criteria introduced by the Musculoskeletal Infection Society (MSIS)
and&#32
&#32
Serum&#32
FDP&#32

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Primary unilateral total knee arthroplasty (TKA) for severe osteoarthritis of the knee, and primary unilateral total hip arthroplasty (THA) for osteoarthritis of the hip, dysplasia of the hip (DDH) and necrosis of the femoral head (40 cases);40 patients underwent primary total joint arthroplasty due to inflammatory diseases such as rheumatoid arthritis and ankylosing spondylitis. 2. Patients undergoing joint revision for non-infectious reasons;Patients undergoing surgical treatment for infection (primary/secondary surgery/debridement and drainage); Patients who underwent a second surgery (temporary prosthesis removal, total hip/knee revision) due to infection; Of these, 59 were infected and 47 were non-infected.

Exclusion criteria

Exclusion criteria: 1. Patients who may refuse to participate in this study; 2. Patients with deep vein thrombosis (DVT); 3. Patients with oral anticoagulants or antiplatelet drugs; 4. Patients with hemophilia A or B; 5. Patients who were given antibiotics 2 weeks before surgery.

Design outcomes

Primary

MeasureTime frame
Plasma FDP, D-dimer and fibrinogen;Serum FDP and D-dimer;Testing and culture of joint fluid;ESR, CRP and IL-6;

Countries

China

Contacts

Public ContactZongke Zhou

West China Hospital, Sichuan University

zongke@126.com+86 13208193509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026